Comparison of Pain Perception in A Group of Pediatric Patients Undergoing Maxillary Primary Molar Extraction Using A Novel Anesthetic Device Versus Traditional Infiltration

NANot yet recruitingINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

August 18, 2025

Study Completion Date

September 18, 2026

Conditions
PainExtraction, Tooth
Interventions
DEVICE

SleeperOne 5

A computerized local anesthetic delivery system (manufactured by Dental Hi-Tec, France) designed to minimize pain perception in children during dental procedures by controlling the pressure and flow rate of anesthetic injection. It will be used to deliver 3% mepivacaine (Mepecaine-L®, Alexandria Co. for Pharmaceuticals, Egypt) during maxillary primary molar extraction in pediatric patients.

PROCEDURE

(Conventional Infiltration Anesthesia)

Local anesthetic solution (3% mepivacaine with no vasoconstrictor), manufactured by Alexandria Co. for Pharmaceuticals, Egypt. It will be administered using a 30-gauge short dental needle and standard dental syringe for conventional infiltration anesthesia during primary maxillary molar extraction in pediatric patients.

All Listed Sponsors
lead

Aya Hesham ElSayed Mohamed ElTanahy

OTHER